Sandoz: How strategic executive communications made the stock market return of Sandoz a success

European pharmaceutical firm Sandoz ran a campaign to promote its 2023 listing on the SIX Swiss Exchange and build brand equity as it spun off from Novartis.

Successfully launching Sandoz as the global leader in generic and biosimilar medicines

The first summary covers the Sandoz SABRE EMEA awards submissions across three categories:

  • DACH geographic area
  • Global Programme: Multiple markets in multiple regions, led from EMEA
  • Pharmaceutical: Rx

The second summary covers Sandoz' entries for the following categories

  • Executive communications
  • Corporate media relations

In summary

2023 was an exceptional year for Sandoz, Europe's largest generic and biosimilar medicines company and one of the pharmaceutical industry's most storied brands. Sandoz' USD 11.2bn spin-off from Novartis in October was one of the most closely watched European business stories of 2023,...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands